Advertisement
Advertisement
ELVN
Enliven Therapeutics, Inc. Common Stock
40.75
USDSponsored
+0.46
+1.14%
May 08, 16:00 UTC -4
Closed
Pre-Market
40.64
-0.11
-0.27%
Enliven Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 2.48B |
| Beta | 0.26 |
| Earnings Per Share (EPS) | -1.86 |
| Price-to-Book (P/B) Ratio | 5.89 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -24.22% |
| Current Ratio | 28.66% |
| Free Cash Flow | -70.25M |
Trending Stocks
Advertisement